Cirrus Therapeutics

Cirrus Therapeutics is a developer of an ophthalmic immunology platform aimed at creating transformative therapies to extend the eye health span and redefine healthy aging for vision. The company's platform delivers genetic instructions directly to the eye via adeno-associated virus (AAV) vectors, restoring IRAK-M production to youthful levels, enabling patients with ocular diseases to receive the necessary treatment.